-
1.发明申请公开(公告)号：US20080132575A1
公开(公告)日：2008-06-05
申请号：US11663165
申请日：2006-05-16
申请人： Jeannie Chow Wong , Aaron S. Cote , Erik A. Dienemann , Kimberly Gallagher , Craig Ikeda , Justin Moser , Pavol Rajniak , Robert A. Reed , Cindy Starbuck , Hsien-Hsin Tung , Qingxi Wang , Benjamin Max Cohen , Vincent R. Capodanno , Brian Sell , Thomas A. Miller
发明人： Jeannie Chow Wong , Aaron S. Cote , Erik A. Dienemann , Kimberly Gallagher , Craig Ikeda , Justin Moser , Pavol Rajniak , Robert A. Reed , Cindy Starbuck , Hsien-Hsin Tung , Qingxi Wang , Benjamin Max Cohen , Vincent R. Capodanno , Brian Sell , Thomas A. Miller
IPC分类号： A61K31/185 , A61P35/00
CPC分类号： A61K31/19
摘要： The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.
摘要翻译： 本发明提供具有特定溶出曲线的药物组合物或结晶组合物，其包含辛二酰苯胺异羟肟酸或其药学上可接受的盐或水合物作为活性成分。 本发明提供了制备所述结晶组合物或药物组合物的方法。 本发明还提供具有特定粒度分布的组合物。
-
2.发明授权Formulations of suberoylanilide hydroxamic acid and methods for producing same 有权辛二酰苯胺异羟肟酸的制剂及其制备方法公开(公告)号：US08450372B2
公开(公告)日：2013-05-28
申请号：US12686843
申请日：2010-01-13
申请人： Jeannie Chow Wong , Aaron S. Cote , Erik A. Dienemann , Kimberly Gallagher , Craig Ikeda , Justin Moser , Pavol Rajniak , Robert A. Reed , Cindy Starbuck , Hsien-Hsin Tung , Qingxi Wang , Benjamin Max Cohen , Vincent R. Capodanno , Brian Sell , Thomas A. Miller
发明人： Jeannie Chow Wong , Aaron S. Cote , Erik A. Dienemann , Kimberly Gallagher , Craig Ikeda , Justin Moser , Pavol Rajniak , Robert A. Reed , Cindy Starbuck , Hsien-Hsin Tung , Qingxi Wang , Benjamin Max Cohen , Vincent R. Capodanno , Brian Sell , Thomas A. Miller
IPC分类号： A61K31/19
CPC分类号： A61K31/19
摘要： The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.
摘要翻译： 本发明提供具有特定溶出曲线的药物组合物或结晶组合物，其包含辛二酰苯胺异羟肟酸或其药学上可接受的盐或水合物作为活性成分。 本发明提供了制备所述结晶组合物或药物组合物的方法。 本发明还提供具有特定粒度分布的组合物。
-
公开(公告)号：US20100119596A1
公开(公告)日：2010-05-13
申请号：US12686812
申请日：2010-01-13
申请人： Jeannie Chow Wong , Aaron S. Cote , Erik A. Dienemann , Kimberly Gallagher , Craig Ikeda , Justin Moser , Pavol Rajniak , Robert A. Reed , Cindy Starbuck , Hsien-Hsin Tung , Qingxi Wang , Benjamin Max Cohen , Vincent R. Capodanno , Brian Sell
发明人： Jeannie Chow Wong , Aaron S. Cote , Erik A. Dienemann , Kimberly Gallagher , Craig Ikeda , Justin Moser , Pavol Rajniak , Robert A. Reed , Cindy Starbuck , Hsien-Hsin Tung , Qingxi Wang , Benjamin Max Cohen , Vincent R. Capodanno , Brian Sell
CPC分类号： A61K31/19
摘要： The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.
-
4.发明申请公开(公告)号：US20100112046A1
公开(公告)日：2010-05-06
申请号：US12686843
申请日：2010-01-13
申请人： Jeannie Chow Wong , Aaron S. Cote , Erik A. Dienemann , Kimberly Gallagher , Craig Ikeda , Justin Moser , Pavol Rajniak , Robert A. Reed , Cindy Starbuck , Hsien-Hsin Tung , Qingxi Wang , Benjamin Max Cohen , Vincent R. Capodanno , Brian Sell
发明人： Jeannie Chow Wong , Aaron S. Cote , Erik A. Dienemann , Kimberly Gallagher , Craig Ikeda , Justin Moser , Pavol Rajniak , Robert A. Reed , Cindy Starbuck , Hsien-Hsin Tung , Qingxi Wang , Benjamin Max Cohen , Vincent R. Capodanno , Brian Sell
CPC分类号： A61K31/19
摘要： The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.
摘要翻译： 本发明提供具有特定溶出曲线的药物组合物或结晶组合物，其包含辛二酰苯胺异羟肟酸或其药学上可接受的盐或水合物作为活性成分。 本发明提供了制备所述结晶组合物或药物组合物的方法。 本发明还提供具有特定粒度分布的组合物。
-
5.发明授权Formulations of suberoylanilide hydroxamic acid and methods for producing same 有权辛二酰苯胺异羟肟酸的制剂及其制备方法公开(公告)号：US08288440B2
公开(公告)日：2012-10-16
申请号：US12686812
申请日：2010-01-13
申请人： Jeannie Chow Wong , Aaron S. Cote , Erik A. Dienemann , Kimberly Gallagher , Craig Ikeda , Justin Moser , Pavol Rajniak , Robert A. Reed , Cindy Starbuck , Hsien-Hsin Tung , Qingxi Wang , Benjamin Max Cohen , Vincent R. Capodanno , Brian Sell
发明人： Jeannie Chow Wong , Aaron S. Cote , Erik A. Dienemann , Kimberly Gallagher , Craig Ikeda , Justin Moser , Pavol Rajniak , Robert A. Reed , Cindy Starbuck , Hsien-Hsin Tung , Qingxi Wang , Benjamin Max Cohen , Vincent R. Capodanno , Brian Sell
IPC分类号： A61K31/19
CPC分类号： A61K31/19
摘要： The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.
摘要翻译： 本发明提供具有特定溶出曲线的药物组合物或结晶组合物，其包含辛二酰苯胺异羟肟酸或其药学上可接受的盐或水合物作为活性成分。 本发明提供了制备所述结晶组合物或药物组合物的方法。 本发明还提供具有特定粒度分布的组合物。
-
6.发明授权Formulations of suberoylanilide hydroxamic acid and methods for producing the same 有权辛二酰苯胺异羟肟酸的制剂及其制备方法公开(公告)号：US08093295B2
公开(公告)日：2012-01-10
申请号：US11663165
申请日：2006-05-16
申请人： Jeannie Chow Wong , Benjamin Max Cohen , Aaron S. Cote , Erik A. Dienemann , Kimberly Gallagher , Craig Ikeda , Justin Moser , Pavol Rajniak , Robert A. Reed , Brian Sell , Cindy Starbuck , Hsien-Hsin Tung , Qingxi Wang , Vincent R. Capodanno
发明人： Jeannie Chow Wong , Benjamin Max Cohen , Aaron S. Cote , Erik A. Dienemann , Kimberly Gallagher , Craig Ikeda , Justin Moser , Pavol Rajniak , Robert A. Reed , Brian Sell , Cindy Starbuck , Hsien-Hsin Tung , Qingxi Wang , Vincent R. Capodanno
IPC分类号： A61K31/19
CPC分类号： A61K31/19
摘要： The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.
摘要翻译： 本发明提供具有特定溶出曲线的药物组合物或结晶组合物，其包含辛二酰苯胺异羟肟酸或其药学上可接受的盐或水合物作为活性成分。 本发明提供了制备所述结晶组合物或药物组合物的方法。 本发明还提供具有特定粒度分布的组合物。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.049 秒)
